If you have a body mass index (BMI) of 30 or higher or a BMI of 27 with weight-related health conditions such as type II diabetes or hypertension and are committed to a treatment plan, you are likely a good candidate
Molecular docking is a powerful tool in drug discovery and understanding proteinligand interactions
It may also interfere with weight loss goals by adding calories, disrupting sleep, lowering food quality, and making it harder to stay consistent with nutrition
Then, after establishing that context, mention that youve researched medical options including GLP-1 medications and ask if your doctor thinks you might be a candidate
Standard qualification criteria include: BMI 30 kg/m (obesity) regardless of comorbidities BMI 27 kg/m (overweight) with at least one weight-related condition such as type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease Age 18 years or older (Wegovy and Saxenda are also approved for adolescents aged 12 and above
